In a previously top-secret research project, the Remicals.de team has been working on a brand-new substance, tentatively named RC-X-404, which has the potential to completely revolutionize the field of research chemicals. Early internal studies suggest an unprecedented combination of extreme potency, exceptional purity, and—perhaps most surprisingly—zero dependency.
“Through targeted molecular reorganization, we managed to create a compound that not only works in incredibly small doses but also fully clears from the body without leaving neurochemical traces,” says one of Remicals’ lead chemists, who wishes to remain anonymous.
RC-X-404 was developed under strictly controlled lab conditions as part of a pilot project. According to our sources, the substance shows receptor binding activity comparable to O-DSMT, even in microdoses—but with a completely new mechanism that allegedly “renders the concept of tolerance obsolete.”
What’s even more exciting: the synthesized samples reportedly reached a purity level of 100.00%—a figure initially thought to be a typo, but later confirmed through multiple laboratory analyses.
Ethical considerations were also a priority in the development. The researchers claim that RC-X-404 is produced in a 100% CO₂-neutral, plant-based bioreactor environment and could eventually serve as a sustainable research tool for advanced neurological studies.
Remicals.de plans to release a limited research batch in the summer of 2025—provided ethical and scientific standards allow it.
Until then, RC-X-404 remains a closely guarded secret—unless you’ve checked your calendar and realized today is…
APRIL FOOLS! 😄
Of course we’re not working on a non-addictive, ultra-pure super chemical (…or are we? 👀). We hope you got a laugh out of this one—and that you stick with Remicals.de, where we take science seriously… and jokes too.